Retraining Reaching in Cerebellar Ataxia
Launched by HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. · Mar 15, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Retraining Reaching in Cerebellar Ataxia," is designed to help people with cerebellar ataxia, a condition that affects balance and coordination. The study aims to see if a specific training method, known as reinforcement-based training, is more effective than standard therapy in improving reaching movements over several weeks. The trial is currently looking for participants aged between 22 and 80 who have experienced cerebellar damage due to causes like stroke, tumor, or degeneration.
Eligible participants will work on exercises that aim to improve their ability to reach and grab objects. To join the study, individuals must not have certain conditions that could interfere with the training, such as significant damage to other parts of the brain, severe symptoms affecting movement, or certain types of pain or vision problems. This trial offers a supportive environment for participants to potentially improve their motor skills and overall quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cerebellar damage from stroke, tumor or degeneration
- • Age 22-80
- Exclusion Criteria:
- • Clinical or MRI evidence of damage to extracerebellar brain (e.g. multiple system atrophy)
- • Extrapyramidal symptoms, peripheral vestibular loss, or sensory neuropathy
- • Dementia ( Mini-Mental State exam \> 22)
- • Pain that interferes with the tasks
- • Vision loss that interferes with the tasks
About Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
The Hugo W. Moser Research Institute at Kennedy Krieger, Inc. is a leading research institution dedicated to advancing the understanding and treatment of neurodevelopmental disorders. With a strong focus on innovative scientific research, the Institute fosters collaboration among experts in various fields, including neuroscience, genetics, and rehabilitation. By conducting rigorous clinical trials and studies, the Institute aims to translate findings into effective interventions that improve the quality of life for individuals with disabilities. Its commitment to excellence in research and patient care positions it as a pivotal player in the advancement of pediatric healthcare and therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Amy J Bastian, PhD, PT
Principal Investigator
Kennedy Krieger Institute and Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials